A small clinical trial demonstrates encouraging early results using an adopted version of CAR T therapy to treat patients with rare autoimmune disorder myasthenia gravis.
Early Success: mRNA & CAR T Therapy To Treat Rare Autoimmune Disease Myasthenia Gravis
